Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5273563
Max Phase: Preclinical
Molecular Formula: C41H62N6O3+2
Molecular Weight: 686.99
Associated Items:
ID: ALA5273563
Max Phase: Preclinical
Molecular Formula: C41H62N6O3+2
Molecular Weight: 686.99
Associated Items:
Canonical SMILES: C[N+](C)(C)CCCC[C@H](NC(=O)[C@H](Cc1ccc(-c2ccccc2)cc1)NC(=O)[C@@H](N)CCCC[N+](C)(C)C)C(=O)NCCc1ccccc1
Standard InChI: InChI=1S/C41H60N6O3/c1-46(2,3)29-15-13-21-36(42)39(48)45-38(31-33-23-25-35(26-24-33)34-19-11-8-12-20-34)41(50)44-37(22-14-16-30-47(4,5)6)40(49)43-28-27-32-17-9-7-10-18-32/h7-12,17-20,23-26,36-38H,13-16,21-22,27-31,42H2,1-6H3,(H-2,43,44,45,48,49,50)/p+2/t36-,37-,38-/m0/s1
Standard InChI Key: VFGNUQAVEBBYLG-QXUSSCGESA-P
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 686.99 | Molecular Weight (Monoisotopic): 686.4872 | AlogP: 4.30 | #Rotatable Bonds: 21 |
Polar Surface Area: 113.32 | Molecular Species: NEUTRAL | HBA: 4 | HBD: 4 |
#RO5 Violations: 1 | HBA (Lipinski): 9 | HBD (Lipinski): 5 | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: 12.16 | CX Basic pKa: 8.14 | CX LogP: -3.88 | CX LogD: -4.68 |
Aromatic Rings: 3 | Heavy Atoms: 50 | QED Weighted: 0.10 | Np Likeness Score: 0.09 |
1. Craig AJ, Ermolovich Y, Cameron A, Rodler A, Wang H, Hawkes JA, Hubert M, Björkling F, Molchanova N, Brimble MA, Moodie LWK, Svenson J.. (2023) Antimicrobial Peptides Incorporating Halogenated Marine-Derived Amino Acid Substituents., 14 (6): [PMID:37312845] [10.1021/acsmedchemlett.3c00093] |
Source(1):